The organs are then transplanted to patients who are suffering heart failure, or are in
endstage lung failure.
They will then be transplanted into patients suffering heart failure or
endstage lung failure.
Endstage lung disease, as defined morphologically, represents the culmination of a "dying-back" process of acini within the secondary pulmonary lobule.
For example, Porter and Paleologos reported the successful use of this strategy in a patient with
endstage lung disease secondary to cystic fibrosis who required a percutaneous endoscopic gastrostomy (4).